hydroxycotinine has been researched along with bupropion in 1 studies
| Studies (hydroxycotinine) | Trials (hydroxycotinine) | Recent Studies (post-2010) (hydroxycotinine) | Studies (bupropion) | Trials (bupropion) | Recent Studies (post-2010) (bupropion) |
|---|---|---|---|---|---|
| 200 | 20 | 99 | 3,392 | 755 | 1,329 |
| Protein | Taxonomy | hydroxycotinine (IC50) | bupropion (IC50) |
|---|---|---|---|
| Acetylcholine receptor subunit alpha | Homo sapiens (human) | 5.2693 | |
| Acetylcholine receptor subunit gamma | Homo sapiens (human) | 5.2693 | |
| Integrin alpha-5 | Homo sapiens (human) | 1.8 | |
| Acetylcholine receptor subunit beta | Homo sapiens (human) | 5.2693 | |
| Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.9373 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.2003 | |
| Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | 1.2028 | |
| Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | 1.367 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 1.9983 | |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 7.9 | |
| Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.0135 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.0848 | |
| Acetylcholine receptor subunit delta | Homo sapiens (human) | 5.2693 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahluwalia, JS; Benowitz, NL; Bronars, CA; Choi, WS; Cox, LS; Faseru, B; Krebill, R; Mayo, MS; Nollen, NL; Okuyemi, KS; Salzman, GA; Snow, TS; Tyndale, RF | 1 |
1 trial(s) available for hydroxycotinine and bupropion
| Article | Year |
|---|---|
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Black or African American; Bupropion; Cotinine; Counseling; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genotype; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Motivation; Nicotine; Oxidoreductases, N-Demethylating; Patient Education as Topic; Patient Selection; Phenotype; Recurrence; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2011 |